HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sudan He Selected Research

Protein Kinases (Protein Kinase)

1/2020MicroRNA-381-3p Functions as a Dual Suppressor of Apoptosis and Necroptosis and Promotes Proliferation of Renal Cancer Cells.
1/2017Receptor-interacting protein kinase 3 promotes platelet activation and thrombosis.
1/2016Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sudan He Research Topics

Disease

13Necrosis
01/2022 - 06/2009
10Neoplasms (Cancer)
11/2020 - 03/2015
8Infections
12/2023 - 10/2014
4Neoplasm Metastasis (Metastasis)
11/2020 - 01/2019
3Autoimmune Diseases (Autoimmune Disease)
10/2023 - 11/2020
3Inflammation (Inflammations)
11/2020 - 01/2017
2Virus Diseases (Viral Diseases)
10/2022 - 01/2020
2HIV Infections (HIV Infection)
11/2020 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 07/2018
2Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
01/2019 - 01/2017
2Thrombosis (Thrombus)
01/2017 - 01/2014
1Leukemia
01/2023
1Peritonitis
01/2023
1Colitis
01/2023
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022
1Rhabdomyosarcoma
10/2022
1Human Influenza (Influenza)
01/2022
1Pathologic Processes
01/2022
1Lung Injury
01/2022
1Carcinogenesis
01/2021
1Bites and Stings (Sting)
01/2021
1Cardiotoxicity
01/2020
1Carcinoma (Carcinomatosis)
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2018
1Deafness (Deaf Mutism)
08/2014
1Carotid Artery Injuries
01/2014
1Neuroinflammatory Diseases
01/2014
1Hemorrhage
01/2014
1Hearing Loss (Hearing Impairment)
07/2011
1Nonsyndromic Deafness
07/2011

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
12/2023 - 07/2011
9Phosphotransferases (Kinase)IBA
01/2022 - 06/2009
3CytokinesIBA
01/2023 - 06/2009
3Antiviral Agents (Antivirals)IBA
01/2022 - 10/2014
3CaspasesIBA
02/2020 - 01/2014
3Protein Kinases (Protein Kinase)IBA
01/2020 - 01/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 06/2009
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2023 - 12/2011
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2020
2Serine (L-Serine)FDA Link
01/2021 - 01/2012
2Chemokine ReceptorsIBA
11/2020 - 01/2020
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2020 - 12/2011
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2016 - 10/2014
1Interleukin-1 Receptor-Associated KinasesIBA
10/2023
1Acetylmuramyl-Alanyl-IsoglutamineIBA
01/2023
1Histocompatibility Antigens Class IIIBA
01/2023
12,4-dinitrofluorobenzene sulfonic acidIBA
01/2023
1ChemokinesIBA
01/2023
1ProteomeIBA
10/2022
1InterferonsIBA
01/2021
1pyrrolidineIBA
11/2020
1Receptor-Interacting Protein Serine-Threonine KinasesIBA
02/2020
1LigandsIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1Caspase 8 (Caspase-8)IBA
01/2020
1Death Domain ReceptorsIBA
01/2020
1metapristoneIBA
01/2019
1N- (6- (2- bromoacetyl)benzo(d)thiazol- 2- yl)acetamideIBA
01/2019
1HhAntag691IBA
07/2018
1Sp1 Transcription FactorIBA
10/2017
1UbiquitinIBA
10/2017
1Transcription Factors (Transcription Factor)IBA
10/2017
1PHA 767491IBA
01/2017
1EndotoxinsIBA
03/2015
1ainsliadimer AIBA
03/2015
1SilverIBA
08/2014
1SiliconIBA
08/2014
1DNA (Deoxyribonucleic Acid)IBA
08/2014
1ferric chlorideIBA
01/2014
18- ethoxy- 2- (4- fluorophenyl)- 3- nitro- 2H- chromeneIBA
01/2014
1Threonine (L-Threonine)FDA Link
01/2012
1Serine-Threonine Kinase 3IBA
01/2012
1N- (4- (N- (3- methoxypyrazin- 2- yl)sulfamoyl)phenyl)- 3- (5- nitrothiophene- 2- yl)acrylamideIBA
01/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2011
1Poly I-CIBA
12/2011
1Caspase InhibitorsIBA
06/2009
1Small Interfering RNA (siRNA)IBA
06/2009

Therapy/Procedure

3Therapeutics
01/2020 - 04/2018
1Quantum Dots (Quantum Dot)
11/2016